Side effects can include injection site reactions, headaches, flushing, and dizziness
I knew exactly how I wanted to eat, but my biology didnt always cooperate
Late in 2023 the Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity and a BMI of 30 or over with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol) for use, in addition to a reduced calorie diet and increased physical activity
WEEKLY ASSESSMENT Your weight, BMI, review of possible side effects, progress with dieting and exercising will be assessed weekly
But its not the first semaglutide pill ever
Supported by the phase 3 OASIS 4 trial, the 64-week study showed a 13.6% average weight reduction in patients taking Semaglutide versus 2.2% with placebo, along with significant improvements in cardiometabolic risk factors